arrow
Back
A

Alasdair MacGowan

Southmead Hospital

59H-index
470Paper Count
1.5WCitation Count
Published Papers 140
Publication Date
Reconciling differences between EUCAST ‘breakpoint-defining doses’ and UK national antimicrobial treatment guidelines
err2026-09-08
err0
errOAAI
errConor Jamieson; Sara E Boyd; Mandy Wootton; David M Livermore; Kieran Hand; Alasdair P Macgowan; Robin A Howe; BSAC Standing Committee on Antimicrobial Susceptibility Testing; null
errShare
errSave
‘Meropenem and fosfomycin against K. pneumoniae’ – Author’s reply
err2026-05-30
err0
PREAI
errAneeq Farooq; Miklas Martens; Marie L.G. Attwood; Patrice Nordmann; Alasdair MacGowan; Sebastian G. Wicha
errShare
errSave
Meropenem and fosfomycin against K. pneumoniae: towards a combination breakpoint using a pharmacometric approach
err2026-03-06
err0
errOAAI
errAneeq Farooq; Miklas Martens; Marie L.G. Attwood; Patrice Nordmann; Alasdair MacGowan; Sebastian G. Wicha
errShare
errSave
Cefalexin use in UK acute pyelonephritis practice: unaddressed challenges in dosing, breakpoints and clinical evidence
err2026-02-26
err0
PREAI
errStephen Hughes; David M Livermore; Sara E Boyd; Gunnar Kahlmeter; Christopher Teale; Phillipa Burns; Nicholas M Brown; Alasdair Macgowan; BSAC Standing Committee on Antimicrobial Susceptibility Testing
errShare
errSave
Importance of reviewing the package insert from gradient strip manufacturers
err2025-12-01
err0
PREAI
errWootton, Mandy; Davies, Leanne; Livermore, David M.; Boyd, Sara E.; MacGowan, Alasdair; Kahlmeter, Gunnar; Howe, Robin
errShare
errSave
Bacteriophage pharmacodynamics studied in an in vitro pharmacokinetic model of infection
err2025-12-01
err0
PREAI
errAttwood, M. L. G.; Griffin, Pippa; Smorowinski, Patryk; Noel, Alan; Haines, Melissa; Millard, Andrew; Adler, Karen; Clokie, Martha; Macgowan, Alasdair Peter
errShare
errSave
Rifampicin as monotherapy for infections caused by Staphylococcus aureus: considerations for not applying 'breakpoints in brackets'
err2025-11-01
err0
errOAAI
errBoyd, Sara E.; Wootton, Mandy; Howe, Robin A.; Livermore, David M.; Macgowan, Alasdair P.; Kahlmeter, Gunnar
errShare
errSave
Applications and benefits of the British Society for Antimicrobial Chemotherapy Resistance Surveillance Project-legacy and future
err2025-10-01
err0
PREAI
errParcell, Benjamin J.; Horner, Carolyne; Reynolds, Rosy; Allen, Michael; Longshaw, Christopher; Livermore, David M.; MacGowan, Alasdair P.
errShare
errSave
Aminoglycoside breakpoints – the EUCAST approach and what this means for the clinician
err2025-08-23
err0
PREAI
errChristian G. Giske; Marlène Amara; Rafael Cantón; Shampa Das; Barbara Holzknecht; Gunnar Kahlmeter; Paul Christoffer Lindemann; Alasdair MacGowan; Joseph Meletiadis; Anouk E. Muller; John Turnidge; Mandy Wootton; Sören Gatermann
errShare
errSave
In vitro activity of NOSO-502, a novel-action antimicrobial, against clinical strains of Enterobacterales including MDR strains
err2025-05-16
err0
PREAI
errAttwood, Marie L. G.; Noel, Alan; Griffin, Pippa; Racine, Emilie; Gualtieri, Maxime; MacGowan, Alasdair
errShare
errSave
The pharmacodynamics of fosfomycin in combination with meropenem against Klebsiella pneumoniae studied in an in vitro model of infection
err2025-01-31
err0
PREAI
errMacgowan, Alasdair P.; Griffin, Pippa; Attwood, Marie L. G.; Daum, Aimee M.; Avison, Matthew B.; Noel, Alan R.
errShare
errSave
Pharmacodynamics of NOSO-502 studied in vitro and in vivo: determination of the dominant pharmacodynamic index driver
err2025-01-13
err0
PREAI
errvan den Berg, Sanne; Attwood, Marie G. L.; Griffin, Pippa; Sassen, Sebastiaan D. T.; Muller, Anouk E.; Raaphorst, Merel N.; Gualtieri, Maxime; Racine, Emilie; Das, Shampa; Noel, Alan R.; Meletiadis, Joseph; Macgowan, Alasdair P.
errShare
errSave
Population pharmacokinetics/pharmacodynamics of minocycline plus rifampicin in patients with complicated skin and skin structure infections caused by MRSA
err2024-10-16
err2
PREAI
errPardos, Sonia Luque; Hope, William; Kotsaki, Antigone; Das, Shampa; Giamarellos-Bourboulis, Evangelos J.; Kontopoulouk, Theano; Akinosoglou, Karolina; O'Hare, Miriam; Attwood, Marie L. G.; Bowker, Karen E.; Noel, Alan R.; Lovering, Andrew M.; Bayliss, Mark A. J.; Evans, Rebecca N.; MacGowan, Alasdair P.
errShare
errSave
Development of antibacterial drug plus bacteriophage combination assays
err2024-07-16
err1
errOAAI
errAttwood, Marie; Griffins, Pippa; Noel, Alan; Josephs, Theo; Adler, Karen; Clokie, Martha; Macgowan, Alasdair
errShare
errSave
errShare
errSave
Antibiotic pharmacokinetics in infected pleural effusions
errTHORAX
IF7.7
err2024-07-04
err0
errOAAI
errArnold, David T.; Read, Liam; Waddington, Oliver; Hamilton, Fergus W.; Patole, Sonia; Hughes, Jessica; Milne, Alice; Noel, Alan; Bayliss, Mark; Maskell, Nicholas A.; MacGowan, Alasdair
errShare
errSave
Fluoroquinolones: clearer evidence and guidance on safety are needed
err2024-05-01
err1
errOAAI
errHamilton, Fergus; Darley, Elizabeth; Macgowan, Alasdair
errShare
errSave
Exposure of Escherichia coli to antibiotic-efflux pump inhibitor combinations in a pharmacokinetic model: impact on bacterial clearance and drug resistance
err2023-10-14
err3
PREAI
errMacgowan, Alasdair P.; Attwood, M. L. G.; Noel, Alan R.; Barber, R.; Aron, Zachary; Opperman, Timothy J.; Grimsey, Elizabeth; Stone, Jack; Ricci, Vito; Piddock, L. J., V
errShare
errSave